LEXX Lexaria Bioscience Corp

$LEXX, To Makingmillions192, Please go back and re-read your posts from the past month. Remember how you hype-drivenly acted as if the results of the 7th human trial would come out right away in late August or early September without taking a moment's rest. After pumping up the stock with numerous posts making it seem like it would skyrocket, you are now amplifying fear with negative posts. Honestly, I don't want to think that you are writing for Lexaria Bioscience or short sellers, but regardless of your intentions, the reality is that your posts seem to be serving them. I am not blaming you—since we are all caught in this trap, getting emotional is meaningless. Now is the time to exercise self-restraint and calmly wait for a rebound. Given the current situation, your posts are only adding salt to the wounds of many retail investors. I would be grateful if you could refrain from posting at least until the results of the 7th human trial are released.

$LEXX The strongest bridge between both companies is Julian Gangolli—former President of GW Pharmaceuticals USA (acquired by Jazz for $7.2B), who now serves as a strategic advisor to Lexaria. Gangolli provides a direct executive line between Jazz’s cannabinoid strategy and Lexaria’s platform. Concurrently, Jazz continues to prioritize rare neurological disorders, recently acquiring Actio Biosciences to expand its pipeline. With Lexaria actively expanding its patent portfolio for treating epilepsy and seizure disorders, DehydraTECH’s ability to boost oral bioavailability creates a natural fit for Jazz’s external drug-delivery alliance strategy. $JAZZ

$LEXX The market and retail investors are pricing this as if Lexaria is turning into a dilution machine. That has never been their history. Mgmt has said very clearly that Human Study #7 was the key to move forward major pharma deals and they’ve fortified the balance sheet to maximize their leverage. Another year of R&D is not in the cards without big pharma collaboration. This will not be trading at a 5m mkt cap if a headline with a billion dollar pharm company partnership pops off. Patience.

$LEXX I do believe MGT is over paid and under performing. I believe Wainw has 450000 warrants to use in the next 18 months, this will also add pressure on the pps... been on this boat for years and staying on it sink or swim... no advice...but the thought of selling now and this does go well would be too painful for me. GLTA

$LEXX it’s really sad, the product is something I would like to invest in but the company running it needs to be nuked and replaced with competent leadershup

$LEXX This should have NEVER slipped under $5. $9.5m in cash on hand for a 6.5m mkt cap?! I’ll take that bet 🤝

$LEXX I don t have some BS prediction for the pps.. But under $3.00 pps after two large RSs says retail investors r f d and mtg plus wainwright equals liars thieves and POS IMHO GLTA FOR ME A BIG BIG.MISTAKE

$LEXX I'm long lexx for the first time since selling at $10-$11. The main reason is that it's trading below cash value and we have seen some strong bounces off of the all time low. There was some decent volume today as well. Looking for $7.50-$10 exit by year end. How the catalysts ahead proves out.

$LEXX when will they ever release the animal studies results? It was scheduled for early September. Gee!

$LEXX Very clear why Bunka donated his stock. He knew what was coming and scammed the deal for a major tax play. Everything at shareholder expense, what a POS

$LEXX what a fucking scam this company has turned out to be. Id sell if there was anything left. Get fucked managment

$LEXX is there any news on the release date of human study? I thought it should have been released by end of september, no?

$LEXX ppl pumping the stock to hell. Truth is that when you have induced warrants and give away more warrants, too, IMO you are telling the market that stock is trash, and the market reacts accordingly.

$LEXX Mr. Christopher using an extra handful of sand in his retail butt lube. Shorts will attack this like sharks to blood until it is under a $. If they do not get shit straight they will go OTC, but guessing the management may want this. It will sink and retail will shed shares and the company boys will be there to gobble up and then when that nod comes to talk about sale of Lexx then the price we be manipulated to skyrocket and the execs will be making bags of money.

$LEXX Hovian, I f ked up too...but hold on and this too shall pass. This is a low point for us ...we both keep going from here "Siempre Avanti" forward and upward my friend!!

$LEXX I see that some of you are betting on the tech. I thought we were always supposed to bet on the jockey. And what have these jockeys done for us in the last couple of years?

$LEXX Market cap below 7 mil, cut by more than half from before the funding. Scumbags would be a compliment Ashley. After screwing all the pawns, some in the know, will make a killing from here..............again. How is this manipulation not a crime?? I know one investor who is contacting the SEC, to see if he can get an investigation going into the trading 90 days before and after news was released. I know an investigation hurts us again, but it will also make mgt. feel the pain. TBD

$LEXX Shorters are having a swell day... but this to shall pass.. it's unfortunately all part of the game.

$LEXX dilution at lower and lower prices is the only history they have. Please pass around whatever you are smoking. 🤦‍♂️

$LEXX I guess they will have to do the same again and discount those warrants now. Could go back below a $1 and then reverse split and then some good news. And then an offering. LEXX hamster wheel.